Company name: Mettrum
Description: Producer and seller of medical cannabis in Canada. The company provides doctor-prescribed patients with pharmaceutical-grade cannabis depending on the particular medical condition. The company offers cannabis in whole-bud and extract form.
Year founded: 2012
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million): 34.50
Business status: Profitable
Revenue (USD Million): 5.85
Gross profit (USD Million): 3.81
Net income (USD Million) -5.55
Earnings before interest, tax, depreciation and amortization (EBITDA): -4.11
Fiscal period: FY 2016
Financing Status: The company was acquired by Canopy Growth for CAD 430 million on January 31, 2017. The acquisition will add to Canopy Growth’s production capacity and bolster its product offering with two new national brands.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 418.23
Last known valuation date: 31-Jan-2017